Research Site

Huelva 21080

1 studies enrolling now · 8 studies all time

What they study most

ATTR Amyloidosis, Breast Cancer, Diabetes Mellitus, Type 2, ER-Positive HER2-Negative Breast Cancer, Heart Failure With Reduced Ejection Fraction, Hyperkalaemia, Multiple Sclerosis, Peripheral Artery Disease

Studies at this site

• OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis — Recruiting now
• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer — Recruiting now
• A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) — Running, not enrolling
• Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease — Completed